Giovanni Rodriguez
Family · Chicago, ILNPI 1174021893
Payments from drug & device makers
Across 119 payments — averaging $29.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Boehringer Ingelheim$567
- AbbVie$324
- Baxter Healthcare$225
- Novo Nordisk$203
- Lilly USA, LLC$200
- plus $908 from 12 others
What the payments were for
- Consulting fees$2256%
- Food & beverage$3,26694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $1,064 |
| Boehringer Ingelheim | 20 | $567 |
| AbbVie | 13 | $324 |
| Baxter Healthcare | 1 | $225 |
| Novo Nordisk | 9 | $203 |
| Lilly USA, LLC | 5 | $200 |
| Bayer | 7 | $165 |
| Exact Sciences | 6 | $165 |
| Corcept Therapeutics | 7 | $157 |
| Pfizer | 5 | $100 |
| Amgen | 4 | $71 |
| Dexcom, Inc. | 2 | $67 |
| Coloplast | 1 | $49 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Viatris Specialty LLC | 2 | $39 |
| Merck | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,491 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 67 | $98,608 |
| RybelsusSemaglutide | 37 | $94,584 |
| OzempicSemaglutide | 53 | $75,450 |
| FarxigaDapagliflozin Propanediol | 66 | $75,081 |
| TradjentaLinagliptin | 42 | $53,274 |
| EliquisApixaban | 28 | $36,644 |
| CreonLipase/Protease/Amylase | 12 | $36,193 |
| MounjaroTirzepatide | 27 | $28,185 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $27,343 |
| EntrestoSacubitril/Valsartan | 20 | $23,310 |
| GemtesaVibegron | 18 | $10,845 |
| RestasisCyclosporine | 12 | $8,574 |
| Sucralfate | 20 | $8,353 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $4,765 |
| Humalog Kwikpen U-100Insulin Lispro | 17 | $3,482 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $203 | $170,03490 claims |
| Boehringer IngelheimJardiance, Tradjenta | $567 | $151,882109 claims |
| AstraZenecaFarxiga | $1,064 | $75,08166 claims |
| AbbVieCreon, Restasis | $324 | $44,76724 claims |
| PfizerEliquis | $100 | $36,64428 claims |
| GSKTrelegy Ellipta, Shingrix | $14 | $30,50541 claims |
| Lilly USA, LLCMounjaro | $200 | $28,18527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Chicago
- Ruth CarricoChicago$582K
- Jamie BroganChicago$282K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Brittony CroasdellChicago$192K
- Stephanie Bradley-MillerChicago$156K
- Elizabeth LegorretaChicago$150K
- Staci GorsonChicago$61K
- Allison MoserChicago$60K
- Darcie McDonaughChicago$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.